AI Healthcare Transformation Surges as Profluent–Lilly Strike $2.25B Gene Editing Deal Brussels 2026
Brussels – April 28, 2026 — Brussels Morning Newspaper – AI healthcare transformation is entering a defining phase as Profluent and Eli Lilly and Company announce a landmark partnership valued at up to $2.25 billion, according to Brussels Morning Newspaper. … Read more
